Across 58 decoded pieces of advice. This scores the state of the evidence behind what they say — not them, and not their honesty. Good creators cover contested ground; that shows up here as mixed.
The high prevalence of vitamin D deficiencies in menopausal women is widely documented in scientific literature, particularly due to metabolic changes and often reduced sun exposure (observational studies, Endocrine Society). The advice to prioritize a blood test rather than indiscriminate supplementation is a prudent and rigorous approach, as serum dosage allows for adjusting intake to actual needs and avoiding excess. The assertion that dietary absorption alone is often insufficient is scientifically supported, as very few foods contain significant amounts of vitamin D. This content presents no notable exaggeration; it encourages a practice of preventive medicine based on biology rather than assumption. There is no miraculous promise here, but rather a pragmatic recommendation for monitoring bone and metabolic health.
The decline of estradiol during perimenopause and menopause is the direct biological cause of major sleep, mood, and metabolic disturbances.
The full read
Research confirms that estradiol plays a major systemic role, well beyond reproduction. Meta-analyses and randomized controlled trials (RCTs) show that, indeed, the drop in estrogen is strongly correlated with hot flashes, which directly disrupt sleep quality (The Menopause Society). Metabolically, observational and clinical studies indicate that this decline influences the redistribution of fat to the abdominal area and can decrease energy expenditure. Regarding mood, the menopausal transition is recognized as a window of vulnerability for depressive symptoms, although the mechanism is multifactorial (biological, psychological, and environmental). The statement is scientifically grounded as a whole, as it highlights established correlations. It avoids the pitfall of oversimplification by mentioning that these changes affect multiple systems, while remaining cautious regarding solutions.
Pelvic pain and cycle disorders (such as fibroids or endometriosis) affect a vast majority of women, yet they should not be trivialized or ignored; they require attentive listening and an active search for solutions rather than simply 'living with it'.
The full read
This publication highlights an epidemiological reality widely validated by science: female discomfort is extremely widespread but too often minimized. Regarding fibroids, scientific data confirm the figures put forward: a major observational study published by Dr. Baird in the American Journal of Obstetrics and Gynecology shows that nearly 70 to 80% of women develop them before the age of 50. Likewise, diagnostic delays for endometriosis are well-documented, with a large international observational study led by Dr. Nnoaham having estimated this waiting period at approximately 7 years. Finally, the assertion that 90% of women will face a menstrual or pelvic disorder is consistent with research on dysmenorrhea (menstrual pain), a synthesis of epidemiological data by Dr. Ju showing that it affects up to 90% of young women. The call to stop normalizing pain and to seek appropriate support is therefore fully supported by science.
The awareness message that rejects the normalization of intimate discomfort and difficult cycles is supported by solid research data. The statistic indicating that up to 80% of women develop fibroids (small benign growths) during their lifetime comes from benchmark observational cohort studies (notably from the US NIH), even if many of them do not experience any daily discomfort. For endometriosis, the assessment of a 7-year diagnostic delay is unfortunately validated by reports from international organizations like the WHO, which highlight the impact of minimizing these severe tensions on quality of life. The overall figure of 90% of women affected by a challenge related to their intimate balance during their lifetime is explained by the high frequency of painful periods, which affect an immense majority of the female population according to public health surveys. Committees of women's health experts agree that listening to one's body and compassionate support are essential to overcoming these imbalances in daily life.
The creator's finding that prolonged sedentary behavior constitutes an independent risk, distinct from a lack of exercise, is scientifically very robust. She rightly relies on the meta-analysis by Patterson et al. (2018), based on large-scale observational studies, which shows that cumulative sitting time of more than 6 to 8 hours per day impairs heart health and longevity, even in active individuals. Furthermore, it is entirely accurate that slow walking is not enough to develop endurance or aerobic fitness, goals that require more sustained effort. However, data in movement science confirm that replacing short moments of sedentary time with light activity provides real benefits in terms of vitality. This clear distinction between the need to break up inactivity and the importance of training with intensity is therefore perfectly validated by current research.
The idea of combining multiple lifestyle habits to support brain health rests on a serious foundation, notably inspired by large randomized controlled trials (RCTs) such as the American US POINTER study, recently shared in JAMA. The MIND diet, rich in green leafy vegetables, berries, and healthy fats, is supported by benchmark observational studies that show a strong link with the preservation of mental acuity. The creator accurately notes that the most impressive figures (such as the 56% greater protection) come from observational studies, which indicate a strong correlation without being an absolute promise of causality. Furthermore, the benefit of stimulating one's mind and taking care of cardiovascular health from midlife onward is validated by long-term cohort studies for maintaining intellectual vitality. While no single miracle solution exists, this comprehensive strategy of accumulating habits remains the most robust according to research for optimizing cerebral well-being over the years.
The creator relies on a very recent study by Piette and Simon published in Gynecological Endocrinology (July 2026), which models data to propose this target of 60 pg/mL to optimize bone and cardiovascular well-being. This analysis is based on a comparison with large randomized clinical trials (the KEEPS and ELITE trials), showing that the observed benefits often coincide with this blood concentration level. However, this is a theoretical extrapolation and not new direct evidence that routine blood monitoring improves longevity. Current scientific consensus does not recommend measuring estradiol to adjust hormone therapy, as these levels fluctuate naturally and evaluation is primarily based on symptoms. Furthermore, the use of these hormones for purely preventive purposes for the heart has not yet been validated by health authorities. The creator herself judiciously nuances her statement by speaking of a 'signal' rather than an official recommendation, which is scientifically rigorous.
The concept of a habit "stack" to support mental acuity rests on particularly solid scientific foundations. The US POINTER randomized clinical trial, published in JAMA (2025), demonstrates that a combined approach incorporating movement, healthy eating, heart monitoring, and an active social life protects memory and cognitive faculties in mature adults. These large-scale results confirm the historic FINGER randomized clinical trial, validating the idea that these routines function best when combined. Regarding the reduction in memory loss risk of up to 56% by accumulating these habits, the creator correctly specifies that this is based on data from observational studies (such as the Rush University cohorts on the MIND diet). However, these percentages should be tempered: randomized clinical trials on the MIND diet alone (such as a 2023 study) reveal more subtle gains in concentration than expected. These figures therefore represent encouraging long-term associations rather than promises of cause-and-effect, an essential nuance that the creator herself takes care to provide.
The analysis by Piette et Simon (2026) skillfully cross-references data from rigorous clinical trials (RCT) such as KEEPS and ELITE to identify this 60 pg/mL threshold, which offers a fascinating perspective on female longevity. Science strongly validates the 'window of opportunity' concept: initiating hormonal support before age 60 or within 10 years post-menopause shows clear protective effects on vessels and bones in these randomized controlled trials. However, targeting a specific number via regular blood tests is not yet validated by global research. Expert consensus reminds us that blood hormone levels fluctuate naturally and that benefits are measured primarily by felt well-being rather than a number on paper. Furthermore, while the protective effect on bone structure is widely recognized, the use of hormonal support solely for heart prevention is not yet validated by health authorities, due to a lack of direct evidence regarding the reduction of major cardiac events. It is, therefore, a captivating scientific signal that paves the way for future personalization, even if it precedes current recommendations.
The increase in blood fats during menopause is a well-documented reality: the longitudinal observational SWAN study confirms that the hormonal transition negatively influences this profile, independent of age or weight. To address this, the efficacy of omega-3 is solid: a meta-analysis of randomized clinical trials (RCT) from the American Heart Association shows that intakes of 2 to 4 g per day significantly reduce triglycerides. Furthermore, small clinical trials confirm that the re-esterified (rTG) form offers better absorption than cheaper forms. Regarding vitamin D, the 4000 IU dose is safe and corresponds to the daily upper limit recommended by health authorities (NIH). Conversely, the idea that vitamin K2 prevents the accumulation of calcium in blood vessels in humans relies primarily on theoretical models; current randomized clinical trials do not yet formally confirm this cardiovascular protective effect.
The claim regarding the rise in triglycerides is based on a rigorous observational study published in Oxford Academic (2025) involving two highly active indigenous populations (the Tsimané and the Mosetén), confirming that for an identical lifestyle, the hormonal transition increases the risk of rising blood fats by a factor of 2.5. The direct impact of the drop in estrogen on lipid balance is, moreover, widely documented by long-term cohort studies. Regarding supplementation, a 2023 meta-analysis of randomized controlled trials (RCTs) confirms that omega-3s significantly decrease triglycerides in menopausal women. The recommended intake of 2g of EPA-rich omega-3s is entirely consistent with the guidelines of institutions like the American Heart Association for supporting cardiovascular health. As for the vitamin D and K2 duo, meta-analyses of RCTs validate the benefit of K2 for preserving bone strength and density post-menopause. However, the claim that K2 prevents calcium from depositing in the arteries relies primarily on a promising theoretical model (the 'calcium paradox') but still lacks direct and indisputable clinical evidence in humans. Finally, the suggestion to have your vitamin D and lipid levels measured through a simple check-up remains an excellent preventative practice.
Endometriosis does not automatically disappear with menopause, pregnancy, or a hysterectomy; although hormonal fluctuations may alleviate symptoms, tissue sensitivity and discomfort can persist.
The full read
This clarification is scientifically very robust and challenges deeply ingrained misconceptions. A systematic review published by the team led by researcher Haas (2020) confirms that this hormone-sensitive tissue can persist and generate discomfort in 2 to 5% of women after menopause. Furthermore, ESHRE guidelines (expert consensus) maintain that removal of the uterus or the natural decline of hormones does not guarantee the disappearance of sensitive areas, as the latter can sometimes produce their own hormonal signals locally. As for pregnancy, observational studies show that the relief experienced is often merely a temporary pause linked to the absence of cycles, without permanently eliminating the origin of the imbalance. The creator's explanation is therefore perfectly accurate and aligned with current knowledge.
Endometriosis does not automatically disappear with menopause, pregnancy, or the removal of the uterus, and these events should not be considered miracle cures.
The full read
This assessment is fully consistent with current knowledge regarding female physiological balance. A synthesis by the World Health Organization (WHO, expert opinion) confirms that there is no way to permanently eliminate these tissues that develop outside their usual area. Regarding the removal of the uterus, a review of observational studies published in *Facts, Views, and Vision in ObGyn* reveals that nearly 21% of women continue to experience physical discomfort after this procedure. Another analysis of observational literature in *Human Reproduction Update* explains that if the fertility glands are preserved, their activity continues to stimulate these sensitive tissues. When cycles cease naturally, clinical (observational) follow-ups show that remaining tissues can stay active due to hormones still produced by other parts of the body, notably body fat. Likewise, while pregnancy offers a welcome pause, observational data confirm that it does not definitively clear the body of these tissues. This message is therefore very valuable for dispelling false promises and guiding toward realistic support for female comfort.
The claim that prolonged sedentary behavior poses a distinct risk, even for active individuals, is solidly validated by science. The meta-analysis of observational studies by Patterson et al. (2018) confirms a marked increase in cardiovascular risks beyond 6 to 8 hours of sitting per day. Furthermore, a large-scale meta-analysis led by Ekelund (2016) shows that a volume of daily exercise very difficult to achieve is required to completely erase the effects of a day spent sitting at a desk. Regarding slow walking, research confirms it is not intense enough to improve overall cardiorespiratory endurance. However, several randomized clinical trials prove that these light interruptions to sitting are sufficient to optimize blood sugar and fat management after meals. The creator's message is therefore particularly accurate and scientifically rigorous.
Research confirms that the transition to menopause alters stress regulation, metabolism, and sleep. The long-term observational study SWAN (Study of Women's Health Across the Nation) clearly associates this period with increased stress sensitivity and sleep disturbances. To address this, a systematic review published in Nutrients (2022) shows that sufficient protein and fiber intake is essential for maintaining muscle mass and satiety in mature women. Avoiding overly strict fasting by widening the eating window to ensure these intakes is an approach validated by randomized clinical trials (RCT) on nutrition. Finally, the importance of reducing stress in the evening via relaxation rituals is supported by the National Sleep Foundation's recommendations (expert consensus) to optimize sleep quality.
The post draws on a viewpoint by researcher Susan M. Ott in the journal *JAMA* (July 2026), an expert opinion emphasizing that the prevention of bone fragility is too often overlooked in midlife women. Regarding the biology of well-being, the acceleration of bone density loss during the menopausal transition is a firmly established scientific fact. The large-scale SWAN observational study has demonstrated that women can lose a significant portion of their bone mass in the years surrounding the cessation of menstruation. To slow this decline, the utility of resistance (strength) training and an adapted nutritional profile is validated by systematic reviews as a pillar of strength and mobility. Conversely, the idea of routinely undergoing a baseline bone scan (DEXA) during perimenopause remains debated: consensus guidelines (such as the USPSTF) generally recommend it at age 65, except in the presence of specific risk factors (genetics, constitutional thinness) where early screening is fully justified.
Avoid unnecessary antibiotics to preserve the gut ecosystem, and regenerate it using a simple triptych: fiber to nourish good bacteria, fermented foods to introduce new ones, and proteins.
The full read
The disruptive impact of antibiotics on the microbiota is scientifically proven: an observational study conducted by Rashid et al. (2015) confirms that certain bacterial populations struggle to fully recover even one year after treatment. Similarly, the hypothesis of a loss of microbial diversity over generations in modern societies is supported by observational research from Justin Sonnenburg's team at Stanford. Regarding reconstruction, the value of fiber and fermented foods is based on solid foundations; a randomized controlled trial (RCT) conducted by Wastyk et al. (2021) demonstrated that a diet rich in fermented products significantly stimulates microbiota diversity while reducing inflammation. Conversely, the claim that the gut "loves" proteins needs to be nuanced, as observational data suggest that an excess of animal proteins can sometimes promote a less protective microbial profile. Finally, the influence of the microbiota on hormonal balance (notably via the estrobolome) is a fascinating field but still relies mainly on expert opinions and biological models, with direct clinical evidence in humans remaining limited.
Research confirms that the gut microbiome plays a key role in hormonal regulation and immunity, a field often referred to as the gut-brain or gut-hormone axis. The negative impact of antibiotics on bacterial diversity is well-documented by observational studies and meta-analyses, showing that some changes can persist over the long term. The suggested nutritional approach is sound: fibers act as prebiotics (food for good bacteria), and fermented foods provide probiotics, which is supported by randomized clinical trials (RCT). There is nothing exaggerated here, as the advice remains focused on fundamental dietary habits. However, it is important to note that microbiome reconstruction is complex and varies significantly from one individual to another depending on their initial health status. The advice is therefore an excellent wellness foundation, scientifically supported by the current nutritional consensus.
To assess and preserve women's heart health, it is necessary to go beyond standard cholesterol screenings and account for their unique biological risk factors, such as pregnancy history, menopausal fluctuations, and inflammatory or hormonal imbalances.
The full read
This global perspective is solidly supported by contemporary longevity science. A major scientific review published by Appelman and colleagues in the *European Heart Journal* (2025) confirms that female reproductive life events, such as pregnancy complications or early menopause, are major indicators of heart health. Furthermore, a meta-analysis of observational studies led by Wu and his team in the *BMJ* (2017) demonstrates that difficulties experienced during maternity nearly double the risk of subsequent cardiovascular frailty. Hormonally-based conditions like polycystic ovary syndrome and immune dysregulation also maintain an environment conducive to internal stress, which influences vascular vitality. By suggesting that the classic assessment grid, modeled on male biology, creates blind spots for women's well-being, the creator aligns perfectly with the latest scientific consensus. There is no exaggeration here: integrating these hormonal and personal markers allows for a much more preventive and personalized approach.
Cardiovascular wellness assessment for women should not be limited to late-stage cholesterol screening in their forties, but must integrate their overall health history very early on: pregnancy complications, hormonal disorders (such as PCOS), immune dysregulation, and the transition to menopause.
The full read
This message is perfectly aligned with the evolution of longevity science and female cardiovascular wellness. A major expert review published by Appelman et al. (2025) in the European Heart Journal confirms that a woman's life course—including her maternity experiences, hormonal balance, and immunity—profoundly influences the flexibility and vitality of her blood vessels well before her forties. Furthermore, a narrative review conducted by Tiwari et al. (2026) in Diagnostics demonstrates that immune health and hormonal history are cornerstone elements for anticipating and personalizing the monitoring of vascular energy. The idea of breaking down silos in body assessment to link hormonal wellness and overall vitality is therefore scientifically indisputable. However, while these biological links are clear, the tools to fluidly integrate all these dimensions into daily comprehensive health check-ups are still in the development stage and need to be generalized.
Sleep disturbances during perimenopause are widely documented, notably by the large-scale observational study SWAN (Study of Women's Health Across the Nation), which confirms a significant increase in nighttime awakenings during this transition. The link between the decline in progesterone—which naturally promotes relaxation and calmness—and difficulty staying asleep rests on well-established scientific foundations. Furthermore, observational work published in the Journal of Clinical Endocrinology & Metabolism indicates that estrogen variations alter the body's sensitivity to stress, which can disrupt the natural rhythm of cortisol. Nevertheless, specifically targeting the 2 a.m. to 5 a.m. window as being purely caused by a hormonal cortisol spike is a simplification. In reality, it is often variations in body temperature (sometimes imperceptible hot flashes) that wake the body first, subsequently causing a secondary increase in alertness. The impact of daily stress described by the creator remains, however, a major and scientifically validated factor influencing the overall quality of rest.
During perimenopause, scientific review articles, such as the one published in Sleep Disturbance and Perimenopause (PMC, 2025), confirm that fluctuating female hormones directly disrupt the quality of our sleep. Progesterone acts as a calming support by stimulating the brain's relaxation receptors; its gradual decline reduces this natural brake, promoting nocturnal awakenings. In parallel, clinical observation studies, such as those shared by the Stanford Sleep Health Program, highlight that the drop in estrogen weakens our ability to modulate cortisol, the hormone of alertness. Without the regulatory shield of these hormones, our stress response system becomes more reactive, which can cause unexpected spikes of alertness in the middle of the night. Furthermore, the 2 a.m. to 5 a.m. window physiologically coincides with the time when our body temperature varies and cortisol begins its natural rise, two phenomena strongly disrupted by the hormonal transition. Research thus validates this complex interaction: these awakenings are not just a matter of mental load, but reflect a temporarily heightened biological sensitivity.
The use of vaginal estrogen in women prone to frequent urinary tract infections may dramatically reduce the risks of systemic infection, hospitalization, and mortality.
The full read
The creator relies on a large observational study (based on the Epic Cosmos database analyzing nearly 1.9 million women) that shows a dramatic association between the application of vaginal estrogen and a reduction in hospitalizations or systemic infections. In terms of wellness science, the efficacy of local estrogen in restoring the intimate ecosystem and spacing out recurrent infections is widely demonstrated by randomized controlled trials (RCTs) and supported by expert recommendations. However, presenting this local treatment as a direct shield against mortality remains an extrapolation. As the creator also notes with great rigor, because the study is observational, it is subject to the healthy user bias: women who have access to this treatment often benefit from more attentive overall healthcare. It is therefore an excellent tool for comfort and local prevention, but it cannot yet be scientifically stated that it directly prevents death.
The large-scale observational cohort study published in the journal Urology (2026) by Justin LaClair's team indeed shows an impressive correlation between the use of local estrogen and a decrease in overall physical complications in women with recurrent intimate imbalances. This gentle, local approach is solidly supported by meta-analyses of randomized controlled trials and recommended by experts at the American Urological Association (AUA, updated in 2025) to regulate flora and preserve urinary comfort. As the creator herself lucidly admits, these data remain observational and do not demonstrate direct causality. There is a strong 'healthy-user bias,' as individuals accessing this type of intimate optimization often benefit, in parallel, from much more rigorous lifestyle and general health monitoring. Presenting local estrogen as a direct solution for preventing death is therefore an exaggerated statement in relation to the state of clinical research. This method nonetheless remains a strategy for longevity and comfort of remarkable value, validated for daily well-being but still offered too infrequently.
The use of vaginal estrogen in women prone to recurrent urinary discomfort significantly reduces the risk of hospitalization, severe infectious complications, and mortality (by 60 to 80%), even though this supportive treatment is currently prescribed to only 5% of these women.
The full read
The study by LaClair et al. (2026), published in the journal Urology, is a vast observational analysis based on real-world data from nearly 1.9 million women. This type of evidence (retrospective database study) is ideal for observing large-scale trends, but it cannot establish a direct cause-and-effect relationship. The data indeed show that women who received a prescription for local hormonal care exhibited significantly lower rates of hospitalization, severe infections, and death. Nevertheless, directly attributing a 60 to 80% reduction in mortality to this routine alone is an oversimplification, as the study did not adjust its results for other lifestyle habits or the overall health status of the participants. It is highly probable that a "healthy user effect" is at play, as individuals who access this type of care often have more rigorous lifestyle and wellness regimens. Finally, the finding that only 5% of the women in question initially receive this treatment option is accurate and underscores a significant lack of access to these women's health solutions.
The concept of the 'estrobolome'—the bacteria that regulate our estrogens—is scientifically validated by review journals (notably in MDPI) that detail how our microbes influence the assimilation of these hormones. Furthermore, fundamental research (such as work from UCLA) confirms that nearly 90% of our serotonin, the molecule of serenity, is produced in the gut through the stimulation of our bacteria. A recent observational and modeling study published in Cell Reports even shows that certain microbial strains can directly synthesize this molecule. The influence of the gut on overall inflammation and mood is also supported by a robust body of observational evidence and narrative reviews describing the gut-brain axis. However, while these biological links are real, clinical evidence such as randomized controlled trials (RCTs) in humans remains limited for recommending standardized wellness solutions. Presenting these interactions as a simple and immediate lever for acting on hormonal balance is therefore slightly premature, though the scientific path is extremely promising.
The idea that the gut influences estrogens is based on a real scientific concept called the "estrobolome," described notably in a review by Baker et al. (2017) published in *Maturitas* (based on observational studies). Certain bacteria do indeed produce enzymes that reactivate estrogens so they can be reabsorbed by the body, although the specific figure of 40% remains a general estimate. Regarding serotonin, it is accurate that nearly 90% to 95% of this molecule is produced in the gut, as confirmed by a study by Yano et al. (2015) in *Cell* (mechanistic evidence). However, it must be clarified that this intestinal serotonin does not directly cross the blood-brain barrier to affect mood, even though there is indirect communication with the brain. Finally, the fact that inflammation diverts tryptophan (the basic component of serotonin and melatonin) toward other pathways is a well-documented biochemical phenomenon, summarized by O'Mahony et al. (2015) in *Behavioural Brain Research*.
Changes in sexual desire and comfort during menopause are common biological phenomena and not an inevitability, as effective solutions exist to treat them.
The full read
The claim that these changes are common and biological is soundly supported by research, particularly regarding genitourinary syndrome of menopause (GSM). Meta-analyses and systematic reviews (such as those published in 'Menopause' or by the 'North American Menopause Society') confirm that the drop in estrogens directly impacts lubrication and vaginal tissues. The idea that these symptoms are treatable is also scientifically validated by randomized controlled trials (RCTs) concerning local hormonal treatments or non-hormonal therapies. The term 'almost entirely treatable' may be perceived as slightly optimistic, as the response to treatments varies according to individuals, medical histories, and psychological or relational factors. The message avoids medical fatalism and encourages a proactive approach, which is consistent with current women's health recommendations. There is no misinformation here, although the multifactorial complexity of libido (physical, emotional, contextual) is simplified here in favor of a biological perspective.
Mary Claire Haver is entirely correct to highlight the limitations of the 2026 pilot study published in *Frontiers in Aging* by Holmes and his team. This open-label clinical trial, conducted on only 40 women for 7 days, indeed presents a high risk of bias due to the absence of a placebo group. Regarding the second study published in the journal *Science* by Yoshino and his collaborators (2021), it is indeed a rigorous randomized controlled trial (RCT). However, this work focused on the metabolic sphere by demonstrating an improvement in insulin sensitivity in postmenopausal women, without ever evaluating the classic physical or cognitive discomforts of the hormonal transition. Currently, no robust double-blind trial confirms the impact of NAD+ precursors on sleep, temperature variations, or mental clarity. Although research on cellular vitality is fascinating, the effectiveness of these molecules for daily hormonal well-being currently rests only on theoretical assumptions and isolated clinical observations.
The creator's position is scientifically very accurate and faithfully describes the current state of research. The rigorous study she mentions, published in the journal Science by Yoshino et al. (2021)—a randomized controlled trial (RCT)—clearly shows that an NAD+ precursor improves muscle insulin sensitivity in postmenopausal, prediabetic women, but it did not measure general well-being, sleep, or hot flashes. Regarding these latter aspects, research is limited to very short pilot studies without a control group, which is more akin to a placebo effect than genuine proof of efficacy. Experts agree that while NAD+ is an exciting avenue for cellular vitality, clinical data are lacking to make it a ritual focused on menopause comfort. The creator's field observation, which qualifies as expert opinion, confirms this absence of tangible results in her patients. Following her recommendation to wait for stronger evidence before investing in these molecules is therefore a very wise approach.
Scientific literature widely confirms that the menopausal transition often begins in the forties, with perimenopause starting on average around age 45, though this may vary. Data from the North American Menopause Society (NAMS) support the idea that hormonal changes precede the final menstrual period by several years, impacting various systems beyond hot flashes. The assertion that "nothing serious is happening" is a reassuring approach aimed at destigmatizing this natural stage, although hormonal fluctuations can indeed increase long-term cardiovascular and bone health risks (observational studies on women's health). The creator's expertise aligns current standards of care with the need for proactive management. There is no exaggeration here; it is a plea for better clinical recognition of an underdiagnosed biological phase.
Optimism is only 25% genetic (notably linked to the oxytocin receptor gene); the remaining 75% is cultivated as a skill by learning to identify pessimistic thoughts and by strengthening social connections to preserve emotional well-being.
The full read
Behavioral genetics research, particularly observational twin studies popularized by psychologist Martin Seligman, confirms that optimism is approximately 25% heritable. Furthermore, a key observational study led by Shelley Taylor and published in PNAS indeed associates variations of the oxytocin receptor gene (OXTR) with optimism and self-esteem. The idea that optimism can be learned through connection practices and cognitive reframing is solidly supported by numerous randomized controlled trials (RCTs) in positive psychology. However, declaring as an absolute fact that unmanaged pessimism will inevitably lead to emotional distress or a depressive state is an exaggeration. Observational data show that pessimism is a significant risk factor for mood, but not an absolute certainty. This perspective nonetheless remains a compelling invitation to train our minds and strengthen our social bonds on a daily basis.
Scientific literature confirms that optimism is a complex trait influenced by an interaction between genetics and the environment. Twin studies (notably a meta-analysis published in Psychological Bulletin) estimate the heritability of an optimistic temperament at around 25-30%, which corroborates the figure provided. The role of the OXTR (oxytocin receptor) gene in emotional regulation and sociability is an active subject in neuroscience (observational studies in PNAS), although linking it directly to 'optimism' is a simplification of a vast biological mechanism. The suggested behavioral approach—cognitive restructuring and maintaining social ties—is the pillar of cognitive behavioral therapy (CBT), the efficacy of which in improving well-being is widely demonstrated by numerous randomized controlled trials (RCT). The discourse remains cautious by avoiding 'magical thinking' and focuses on mental training, which is scientifically supported as a form of behavioral neuroplasticity.
Mary Claire Haver's assessment regarding the lack of preparation for future practitioners is scientifically supported. A questionnaire-based study published in the Mayo Clinic Proceedings (Kling et al., 2019) confirms that only 6.8% of internal medicine and gynecology residents feel fully equipped to manage this life transition. Physiologically, the fact that estrogen acts well beyond fertility is a fact firmly established by fundamental research: estrogen receptors are present in vessel walls, bone tissue, and the brain, influencing energy and cognitive vitality. Furthermore, the North American Menopause Society (NAMS) agrees in its expert opinions on the urgent need to improve clinical training in the face of this growing need. The creator's call to reform curricula is a legitimate public health plea, entirely consistent with current professional survey data.
Research in the economics of happiness and psychology indeed supports the existence of a U-shaped curve of subjective well-being over the lifespan. A major cross-sectional study published in 'Social Science & Medicine' (Blanchflower & Oswald, meta-analysis/observational data) confirms this trend in many countries. This mid-life trough is well-documented, although its intensity varies according to socioeconomic factors. The association made by the creator between this nadir and perimenopause is a logical observation consistent with the lived reality of many women, although science cannot isolate hormonal biology as the sole cause of this complex phenomenon. It is not a medical inevitability, but rather a time window where psychosocial stressors (family life, career, aging) often accumulate. The idea that well-being improves after this phase is supported by data showing an improvement in emotional regulation with age.
The concept of the U-shaped happiness curve is supported by large observational studies, notably the work of economist David Blanchflower published in the Journal of Population Economics, which indeed identifies a low point in well-being around age 47-48 in developed countries. This transition often coincides with periods of significant hormonal variation and midlife stress. However, research is not unanimous: longitudinal studies conducted by psychologists like Nancy Galambos suggest that the trajectory of happiness is more complex and does not systematically follow this U-shape for everyone. Furthermore, although the parallel with perimenopause is clinically highly relevant to explain this feeling of chaos, the data on the happiness curve come from global demographic surveys and not from biological analyses measuring the direct impact of hormones. This phase should therefore be understood as a general trend and an opportunity for personal re-evaluation rather than as an absolute biological inevitability.
It is physiologically established that the drop in estrogen during the transition of one's forties accelerates the reduction of cutaneous collagen, a fact widely documented by observational research. Regarding supplementation, a broad review of meta-analyses published in the Aesthetic Surgery Journal (2026) supports that hydrolyzed collagen promotes skin hydration and elasticity. Nevertheless, a meta-analysis of randomized controlled trials (RCTs) published by Dr. Myung in the American Journal of Medicine (2025) provides a significant caveat, showing that meaningful benefits primarily stem from low-quality or industry-funded studies. The assertion that collagen supplementation specifically targets and corrects the loss of firmness due to hormonal decline after age 40 therefore remains an appealing but exaggerated extrapolation. Although these supplements provide useful molecular building blocks for protein synthesis, solid and independent evidence that they can directly counteract the cutaneous effects of menopause is still lacking.
Decreased libido, pain during intercourse, and arousal disorders during menopause are not an unavoidable fate linked to age, but rather treatable symptoms that can be managed.
The full read
This advice is based on a solid scientific foundation regarding genitourinary syndrome of menopause (GSM). Research, particularly the recommendations of the North American Menopause Society (NAMS, official position), confirms that estrogen deficiency directly impacts vaginal tissues and sexual function. The efficacy of treatments, such as local vaginal estrogen or certain hormonal therapies, is widely demonstrated by randomized clinical trials (RCT). The assertion that these symptoms are not merely an inevitability is therefore medically grounded, as validated solutions exist to improve quality of life. It is important to note, however, that while the majority of symptoms are treatable, response to treatment varies according to individuals and multifactorial causes (hormonal, psychological, relational). The advice encourages seeking professional medical opinion, which is the recommended approach for personalizing care.
The observation that menopause affects overall well-being (sleep, bone strength, hair quality) is solidly validated by research. For example, the guidelines from the North American Menopause Society (NAMS, expert consensus) confirm that hormone therapy helps maintain bone strength and relieve intimate discomfort. The assertion that dosages must be personalized is also supported: the British Menopause Society (BMS, clinical practice recommendations) advocates for a tailored approach, adjusted according to individual tolerance. Regarding the idea that a dose that eases symptoms does not necessarily provide long-term protection, reviews of randomized clinical trials (RCT) show that even very low doses of hormones are generally sufficient to preserve bone density. Saying that feeling well does not mean being protected is therefore slightly exaggerated, as the protective effect on the skeleton is activated at even the lowest clinical dosages. Nevertheless, the individual variability of hormone absorption depending on the format used (transdermal or oral) is a well-documented biological fact that fully justifies personalized follow-up.
Mary Claire Haver’s recommendation is based on particularly solid and up-to-date science. The 150-minute cardio recommendation aligns with global guidelines from the WHO (Bull et al., 2020), derived from large reviews and observational studies linking this dose to a healthy cardiovascular system. Regarding the 100 minutes of strengthening, the meta-analysis by Shailendra et al. (2022) shows that such a practice actively supports general vitality and cellular longevity. Fascinatingly, the observational study by Ji et al. (2024) confirms that women experience increased longevity gains from an exercise volume often lower than that of men. Furthermore, the positive impact of strength training on managing blood pressure in women is well-supported by the observational study by Park & Park (2024). This comprehensive and accessible approach of 35 minutes per day constitutes an ideal balance for optimizing daily fitness.
Aim for at least 250 minutes of physical activity per week (approximately 35 minutes per day), ideally split into 150 minutes of moderate cardio and 100 minutes of muscle strengthening, while keeping in mind that women benefit from improvements in longevity and blood pressure at effort volumes often lower than those of men.
The full read
Mary Claire Haver's advice is supported by robust public health data. The 150 minutes of moderate cardio per week are perfectly aligned with global benchmarks validated by large population follow-up studies (Piercy 2018, Bull/WHO 2020) to preserve cardiovascular well-being. For strength training, a meta-analysis by Shailendra (2022) shows that approximately 60 minutes per week is already sufficient to optimize life expectancy, which proves that the positive impact begins very early. The female advantage—namely, obtaining equal or greater longevity gains at lower exercise volumes—is supported by a vast prospective cohort study (Ji 2024, JACC) and analyses of the NHANES database (He 2025). Finally, the specific link between strength training and reduced blood pressure in women is based on an observational study by Park & Park (2024). Although these population data are not all derived from randomized clinical trials (RCTs) that would prove a direct and isolated causality for every movement, this comprehensive exercise prescription remains scientifically sound for daily health.
The observational study by Shillito et al. (2026), involving more than 10,000 women, confirms that a large proportion of menopausal women do not meet the recommendations regarding sleep and physical activity. Regarding the impact of hormonal change on the body, the review by Collins et al. (2019) shows how the decline in estrogen directly weakens muscle strength and bone structure. The estimates of a 15% loss in muscle mass and 10% loss in bone density are consistent with the narrative review by Buckinx and Aubertin-Leheudre (2022) on changes in physical condition after menopause. To counter this decline, the assertion that muscle strengthening supports longevity by 10% to 20% is solidly based on a large-scale meta-analysis conducted by Momma et al. (2022). Finally, the role of deep sleep in the clearance of cerebral metabolic waste and the regulation of blood glucose is well established by observational data on biological rhythms. This preventive and nuanced discourse is therefore perfectly aligned with the current state of wellness science.
The creator draws on a recent observational study in the journal *Menopause* showing that few women meet these goals post-menopause. The figures regarding the decline in bone density and muscle strength during this period are consistent with longitudinal studies on the supportive role of estrogen. The impact of resistance training on longevity (a 10-20% reduction in all-cause mortality risk) is robustly supported by a meta-analysis by Momma et al. (2022) in the *British Journal of Sports Medicine*. Regarding protein, recommendations from the international *PROT-AGE* research group effectively advise aiming for more than 0.8 g/kg to maintain muscle mass with age. As for sleep, clinical imaging work (notably by Shokri-Kojori et al., 2018) confirms that deep rest helps clear metabolic waste from the brain, although the direct link to long-term cognitive decline is still under study. The discourse is particularly balanced, as the creator herself points out that this research describes strong associations rather than absolute proof of cause and effect.
If physical perimenopause symptoms (such as night sweats or hot flashes) regularly disrupt your sleep, it is advisable to seek ways to soothe them in order to maintain your current comfort and potentially support your long-term cognitive health.
The full read
The creator faithfully draws on an observational study from Harvard University (Hu et al., 'Menopause', 2026) showing that perimenopausal sleep disturbances, when linked to night sweats, are associated with slight declines in cognitive faculties decades later. This link is corroborated by other observational work, notably the SWAN study (2026) and research from the University of Pittsburgh (Thurston et al., 'Neurology', 2022), which link these nighttime awakenings to signals of brain vulnerability. The creator demonstrates remarkable rigor by pointing out the study's limitations himself, including its observational nature and the use of self-reported sleep data. The assertion that mere light sleep does not impact future mental agility is validated by this study, as no significant correlation was detected in women not awakened by these symptoms. Although no randomized controlled trial (RCT) yet proves that treating these awakenings prevents long-term decline in attention, recent randomized controlled trials ('Menopause', May 2026) demonstrate that targeted behavioral approaches greatly improve the quality of life and nighttime comfort of women. Taking care of one's nights during this life transition therefore remains an excellent overall strategy for optimizing vitality.
Treat night sweats and hot flashes that disrupt sleep during perimenopause, as these specific awakenings are associated with a decline in mental vitality decades later, unlike simple light sleep.
The full read
The creator relies on a recent observational study published in the journal Menopause (conducted by researchers at Harvard) that followed approximately 2,100 women, which provides a solid level of observational evidence for identifying long-term correlations. This research intriguingly shows that it is not sleep difficulties in general, but specifically awakenings caused by thermal variations (hot flashes), that are linked to lower memory scores years later. These data align with other large observational studies, notably the famous U.S. cohort SWAN (Study of Women's Health Across the Nation), which also links the severity of these nocturnal heat waves to fluctuations in mental clarity. The creator demonstrates exemplary rigor by highlighting herself that this study is observational, based on subjective reports, and does not prove a cause-and-effect relationship. Her message is not alarmist and focuses solely on the importance of seeking comfort solutions to preserve one's future well-being.
After menopause, the drop in hormones often weakens the balance of the intimate area. Using gentle local estrogen formulas can help restore optimal comfort and effectively prevent recurrent discomfort or urinary issues.
The full read
Dr. Haver highlights an essential yet taboo subject: the impact of menopause on the balance of the intimate and urinary areas. Research fully supports her protective approach, confirming that local care of this area is a key to well-being that should not be overlooked. A 2020 meta-analysis, encompassing several randomized clinical trials (RCTs), shows that the application of local estrogen reduces the risk of recurrent urinary discomfort by nearly 58% compared to a placebo. Furthermore, consensus guidelines published in 2025-2026 by the American Urological Association (AUA) and the American Urogynecologic Society (AUGS) place these gentle local formulas as a first-line treatment to restore intimate comfort. Unlike mood fluctuations or hot flashes, these intimate sphere discomforts tend to worsen over time if left unaddressed, which validates the importance of early intervention.
This recommendation to aim for 25 g of fiber per day is based on particularly solid scientific foundations. Regarding the microbiome, a systematic review published in the journal *Nutrients* confirms that fiber fermentation produces butyrate, a valuable compound that nourishes our digestive cells and maintains a calm intestinal environment. In terms of metabolic vitality, a large meta-analysis of clinical trials published in *The American Journal of Clinical Nutrition* shows that soluble fibers help regulate the sugar response and support insulin sensitivity. For the gut-brain axis, recent work in the *Journal of Agricultural and Food Chemistry* confirms that the quality of our diet influences stress management and mood through chemical messengers produced in our gut. It must be noted, however, that the evidence directly linking fiber to improved overall mental clarity in humans remains primarily derived from observational studies and still requires further investigation. Finally, the use of psyllium is a backup option validated by wellness experts to easily bridge a daily intake deficit.
The positive impact of progesterone on restless nights rests on a solid scientific foundation: a meta-analysis of randomized controlled trials (RCTs) conducted by Nolan's team confirmed that it improves subjective sleep quality and accelerates sleep onset by activating the brain's calming receptors. Furthermore, a randomized controlled trial from the University of British Columbia highlights its effectiveness in calming nocturnal thermal fluctuations during life transitions. Conversely, the notion that it directly relieves PMS and PMDD is highly debated. A systematic review by the Cochrane Collaboration indicates that progesterone shows no benefit superior to a placebo for these mood fluctuations. Research suggests instead that PMDD discomfort stems from increased neuronal sensitivity to this hormone, which aligns with the fact that some individuals do not tolerate it well. Finally, regarding transdermal estradiol, a literature review published in Frontiers supports that its application helps stabilize physical and emotional well-being when carefully combined with progesterone.
Taking progesterone in the evening helps restore calm, deep sleep, soothes cycle-related discomforts (premenstrual syndrome), and protects uterine balance when used in combination with estrogens, with the option of vaginal application in cases of sensitivity.
The full read
The effect of micronized progesterone on sleep quality is supported by randomized clinical trials (RCTs), such as the study by Caufriez et al. (2011), showing that it interacts with brain relaxation receptors to promote deeper rest. Its essential role in maintaining the comfort and protection of the uterine lining when using estrogens is also firmly validated by large clinical trials (such as the landmark PEPI study). The alternative of vaginal administration to bypass digestive discomfort or excessive drowsiness is based on observational studies and expert opinion, which confirm good local absorption. However, the beneficial effect on premenstrual dysphoric disorder (PMDD) is overstated: reviews of the scientific literature indicate that individuals with PMDD often exhibit abnormal sensitivity to progesterone fluctuations, and that adding it can sometimes exacerbate mood swings rather than soothe them.
The gradual decrease in hormone production during menopause alters the ecosystem and elasticity of the intimate area, which can lead to a loss of sensitivity and comfort. This phenomenon, known as genitourinary syndrome of menopause (GSM), is documented by consensus statements from professional health organizations such as the American Urological Association (expert opinion). Meta-analyses, notably from the Cochrane collaboration, and numerous randomized controlled trials (RCTs) demonstrate that the application of low-dose hormone-based local care (such as targeted moisturizing creams) helps restore natural hydration, regenerate delicate skin, and regain better sensitivity. The 'reversible' aspect mentioned by the creator is therefore observed in the elasticity and responsiveness of tissues through these targeted treatments. However, the overall loss of volume in the outer labia is also linked to the natural aging of skin tissues, which is not entirely corrected by these methods. Furthermore, other popular approaches such as intimate laser therapy still lack strong evidence, with some rigorous studies (RCTs) showing no superiority over a simple placebo effect.
The use of low-dose vaginal estrogen in postmenopausal women is associated with a 15% to 21% decrease in the risk of rectal cancer, in addition to the well-established benefits of this treatment for intimate comfort, tissue elasticity, and urinary protection.
The full read
The creator accurately cites the Finnish study by Siitonen et al. (published in the journal Maturitas), which is a large observational case-control study involving over one million women. This research highlights a correlation between low-dose vaginal estrogen and a reduction in the risk of rectal cancer ranging from 15% to 21%. The nuance provided by the creator is exemplary: he clarifies that this is an association and not a causal link, the latter of which would require validation through randomized controlled trials (RCTs). Furthermore, the other benefits described regarding intimate comfort, lubrication, and the prevention of recurrent urinary discomfort are strongly supported by numerous meta-analyses and clinical trials. This potential protective effect on the rectum, while clinically plausible through local diffusion, should therefore be viewed as a promising bonus rather than the primary reason for adopting this care regimen.
The use of low-dose vaginal estrogen for intimate comfort during menopause is associated with a 15 to 20% reduction in the risk of rectal cancer, although this should not be the primary reason for starting this treatment.
The full read
The creator draws very accurately on a large Finnish observational study (Siitonen et al., 2025, published in Maturitas) that highlights this encouraging link. She correctly notes the limitations of this type of evidence, which is unable to establish direct causality, particularly due to user bias where individuals consult their doctors more regularly and benefit from better follow-up. Furthermore, the efficacy of this local treatment for restoring intimate tissues and reducing urinary discomfort is already widely validated by scientific consensus, such as that of the Menopause Society. Regarding digestive protection, large historical randomized clinical trials (such as the Women's Health Initiative) had already observed a decrease in colorectal cancers with systemic hormones, which makes this local pathway very plausible but still in need of confirmation by rigorous prospective trials. The message is therefore perfectly balanced, presenting this data as a reassuring bonus rather than an established therapeutic promise.
It is quite accurate that the drop in estrogen is closely linked to an increase in joint sensitivity, as these hormones play a protective role for our tissues. Furthermore, an analysis from the Women's Health Initiative (WHI) randomized clinical trial shows that hormonal support can significantly improve joint comfort in menopausal women. Additionally, observational studies published in the journal Climacteric confirm that a large majority of women experience stiffness and physical discomfort during this transition. However, the term "musculoskeletal syndrome of menopause" is a recent and popularized phrasing that has not yet been officially standardized by the scientific community. Finally, while frozen shoulder often affects women in this age group, its direct and unique link to the decline of estrogen alone still lacks solid evidence, as other mechanical or metabolic factors come into play. This perspective nevertheless remains very interesting for encouraging a comprehensive approach to movement and flexibility during this period of life.
Estrogen fluctuations during the hormonal transition do indeed influence brain regions managing emotions, as confirmed by a literature review published in *Frontiers in Neuroendocrinology*, which shows that these variations alter stress sensitivity. Furthermore, the link between stress, elevated cortisol, and changes in sugar regulation (insulin sensitivity) at midlife is documented by observational studies, notably in the *Journal of Clinical Endocrinology & Metabolism*. As for the proposed wellness solutions, box breathing and nature breaks have been the subject of randomized controlled trials (RCTs) synthesized in a meta-analysis in *Scientific Reports*, proving their effectiveness in soothing the nervous system. Nevertheless, the assertion that old stress management methods systematically fail is an interesting field observation, but it lacks standardized scientific evidence. Overall, this approach scientifically validates a real experience while proposing accessible calming rituals.
The idea of actively reducing sources of daily tension is based on solid foundations in behavioral psychology for maintaining mental balance. As for the 20-minute break, a cohort study published in *Frontiers in Psychology* (Hunter et al., 2019) confirms that a 20-minute period of disconnection (such as sitting in nature or walking) significantly lowers cortisol levels. Using movement to consume circulating sugar is also very consistent: a meta-analysis of randomized controlled trials (Buffey et al., 2022) demonstrates that brief sessions of walking or light bodyweight exercise help capture blood sugar through muscle contraction. The concept of a 'cortisol reset' is, however, a somewhat simplified image, as this hormone follows a natural 24-hour biological rhythm that does not reset on demand. Finally, while short-term physical activity supports energy regulation, presenting these micro-movements as a direct bulwark against insulin resistance linked to chronic stress remains an encouraging extrapolation that is still poorly documented over the long term.
The recommendation not to exhaust oneself with exercise while in a caloric restriction is validated by science: a consensus from the Endocrine Society (2017) confirms that a severe energy deficit directly disrupts hormones related to fertility and vitality. Furthermore, healthy fats are essential as they serve as building blocks for hormones, while fiber supports the estrobolome (the gut bacteria that regulate estrogen), as highlighted in an observational study published in The Journal of Nutrition. However, the claim that sacrificing fiber for protein is the current 'biggest mistake' among women is more of an expert opinion and lacks comprehensive comparative data. Nevertheless, the approach of nourishing the body to stabilize hormones rather than imposing intense physical stress on it rests on very solid biological foundations.
Research solidly validates the existence of the "menopause belly": the longitudinal observational SWAN study shows that declining estrogen leads to a measurable redistribution of fat from the hips to the abdomen in the form of visceral fat. Scientific literature reviews confirm that this morphological change is biological in nature. However, regarding overall weight gain, a benchmark study on energy expenditure (Pontzer et al., Science) shows that the metabolic slowdown during this period of life is primarily linked to general aging and the natural loss of muscle mass, rather than menopause itself. The advice not to rely solely on "eating less" is quite relevant: overly severe caloric restrictions risk breaking down muscle mass, which further weakens resting energy expenditure. Finally, the British Menopause Society guidelines agree that it is preferable to focus on dietary quality and muscle strengthening to support metabolic health.
The importance of muscle strengthening and protein for maintaining physical fitness during menopause is firmly established by research. A major meta-analysis (Tan et al., 2023, published in BMC Women's Health) encompassing 27 randomized clinical trials confirms that resistance training is the only type of exercise that significantly increases lean mass in menopausal women. Furthermore, recent clinical trials show that the muscles of menopausal women respond extremely well to this physical stimulus. As for protein, its structural role is undeniable, even if clinical data on increased nutritional needs specific to this transition period remain of moderate quality (2024 narrative review, MDPI). Conversely, the direct influence of declining estrogen on muscle loss is often exaggerated. A comprehensive review (Menzies et al., 2026, published in the Journal of Cachexia, Sarcopenia and Muscle) indicates that the decline in muscle vitality observed during this period is primarily linked to general aging and reduced physical activity, rather than to hormonal decline alone. This same study shows that estrogen supplementation alone has a negligible impact on muscle gain, confirming that movement remains the most powerful signal for stimulating growth.
